Literature DB >> 12798892

Suppression of pelvic pain during hysteroscopy with a transcutaneous electrical nerve stimulation device.

Carlo De Angelis1, Giuseppina Perrone, Giuseppina Santoro, Italo Nofroni, Lucio Zichella.   

Abstract

OBJECTIVE: To evaluate the effectiveness of transcutaneous electrical nerve stimulation (TENS) as a pain control method during office hysteroscopy.
DESIGN: A prospective, randomized study.
SETTING: Centre for Minimally Invasive Surgery, Department of Gynecological Science and Perinatology, "La Sapienza" University, Rome, Italy. PATIENT(S): One hundred forty-two patients undergoing office hysteroscopy. INTERVENTION(S): Application of a TENS device on the patient's abdomen before and during office hysteroscopy. MAIN OUTCOME MEASURES: The level of pain experienced by the patients was assessed using a 10 cm visual analog scale; the side effects and changes in the hemodynamic parameters were evaluated. RESULT(S): The patients treated with TENS during hysteroscopy (group A, n = 71) were compared with a control group (group B, n = 71) on whom the TENS device was not used. The women in the TENS group experienced a significantly lower level of pain during hysteroscopy. No differences in side effects were observed between both group. CONCLUSION(S): TENS is a simple, efficient, and safe method of relieve pain during office hysteroscopy.

Entities:  

Mesh:

Year:  2003        PMID: 12798892     DOI: 10.1016/s0015-0282(03)00363-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

Review 1.  Updates in office hysteroscopy: a practical decalogue to perform a correct procedure.

Authors:  Salvatore Giovanni Vitale; Simone Bruni; Benito Chiofalo; Gaetano Riemma; Ricardo Bassil Lasmar
Journal:  Updates Surg       Date:  2020-02-01

Review 2.  Transcutaneous electrical nerve stimulation for acute pain.

Authors:  Mark I Johnson; Carole A Paley; Tracey E Howe; Kathleen A Sluka
Journal:  Cochrane Database Syst Rev       Date:  2015-06-15

Review 3.  Pain relief for outpatient hysteroscopy.

Authors:  Gaity Ahmad; Sushant Saluja; Helena O'Flynn; Alessandra Sorrentino; Daniel Leach; Andrew Watson
Journal:  Cochrane Database Syst Rev       Date:  2017-10-05

Review 4.  Characterising the Features of 381 Clinical Studies Evaluating Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Relief: A Secondary Analysis of the Meta-TENS Study to Improve Future Research.

Authors:  Mark I Johnson; Carole A Paley; Priscilla G Wittkopf; Matthew R Mulvey; Gareth Jones
Journal:  Medicina (Kaunas)       Date:  2022-06-14       Impact factor: 2.948

5.  The Effects of Transcutaneous Electrical Nerve Stimulation on Post-Episiotomy Pain Severity in Primiparous Women: A Randomized, Controlled, Placebo Clinical Trial.

Authors:  Seyedeh Soma Zakariaee; Roonak Shahoei; Leila Hashemi Nosab; Ghobad Moradi; Mina Farshbaf
Journal:  Galen Med J       Date:  2019-08-14

6.  Effects of high-frequency, high-intensity transcutaneous electrical nerve stimulation versus intravenous opioids for pain relief after hysteroscopy: a randomized controlled study.

Authors:  Birgitta Platon; Sven-Egron Thörn; Clas Mannheimer; Paulin Andréll
Journal:  Obstet Gynecol Sci       Date:  2020-07-28

7.  Comparison between sensory and motor transcutaneous electrical nervous stimulation on electromyographic and kinesiographic activity of patients with temporomandibular disorder: a controlled clinical trial.

Authors:  Annalisa Monaco; Fabrizio Sgolastra; Davide Pietropaoli; Mario Giannoni; Ruggero Cattaneo
Journal:  BMC Musculoskelet Disord       Date:  2013-05-15       Impact factor: 2.362

8.  A Comparative Study between Transcutaneous Electrical Nerve Stimulation and Fentanyl to Relieve Shoulder Pain during Laparoscopic Gynecologic Surgery under Spinal Anesthesia: A Randomized Clinical Trail.

Authors:  Zahra Asgari; Zahra Tavoli; Reihaneh Hosseini; Masoomeh Nataj; Fatemeh Tabatabaei; Fatemeh Dehghanizadeh; Hosein Haji-Amoo-Assar; Mahdi Sepidarkish; Ali Montazeri
Journal:  Pain Res Manag       Date:  2018-03-18       Impact factor: 3.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.